Human Genome Epidemiology Literature Finder
|
Records 1 - 17 (of 17 Records) |
| Query Trace: Recurrence and meta-analysis and BRAF[original query] |
|---|
| BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis. Medicine 2012 Aug . Tufano RP, Teixeira GV, Bishop J, Carson KA, Xing M |
| The prognostic significance of the BRAF V600E mutation in papillary thyroid carcinoma detected by mutation-specific immunohistochemistry. Pathology 2013 Dec 45 (7): 637-44. McKelvie Penelope A, Chan Fiona, Yu Yong, Waring Paul, Gresshoff Irma, Farrell Stephen, Williams Richard |
| [Association of BRAF(V) 600E mutation with clinical pathological features in papillary thyroid carcinoma: meta-analysis]. Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery 2014 Sep 49 (9): 759-64. Yan Kangkang, Lin Xuejun, Li Shuang, Bao Honghong, Zhao Longyu, Liu X |
| The association between BRAF (V600E) mutation and pathological features in PTC. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2014 Nov 271 (11): 3041-52. Liu Xin, Yan Kangkang, Lin Xuejun, Zhao Longyu, An Wenxiu, Wang Chunpeng, Liu Xiaodo |
| BRAF(V600E) Is Correlated with Recurrence of Papillary Thyroid Microcarcinoma: A Systematic Review, Multi-Institutional Primary Data Analysis, and Meta-Analysis. Thyroid : official journal of the American Thyroid Association 2015 Dec . Chen Yufei, Sadow Peter M, Suh Hyunsuk, Lee Kyu Eun, Choi June Young, Suh Yong Joon, Wang Tracy S, Lubitz Carrie Cunningh |
| Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis. World journal of surgical oncology 2016 14 (1): 241. Liu Chunping, Chen Tianwen, Liu Zemi |
| The BRAF V600E mutation predicts poor survival outcome in patients with papillary thyroid carcinoma: a meta analysis. International journal of clinical and experimental medicine 2015 8 (12): 22246-53. Li Jianhua, Zhang Shuijun, Zheng Shouhua, Zhang Danhua, Qiu Xingua |
| Meta-Analyses of Association Between BRAF(V600E) Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2016 Feb 38 (2): 763-776. Zhang Qing, Liu Shao-Zheng, Zhang Qing, Guan Yan-Xing, Chen Qing-Jie, Zhu Qin-Y |
| Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis. OncoTargets and therapy 2016 9 6965-6976. Su Xingyun, Jiang Xiaoxia, Wang Weibin, Wang Haiyong, Xu Xin, Lin Aihui, Teng Xiaodong, Wu Huiling, Teng Liso |
| TERT promoter Mutation and Its Association with Clinicopathological Features and Prognosis of Papillary Thyroid Cancer: A Meta-analysis. Scientific reports 2016 Nov 6 36990. Liu Chunping, Liu Zeming, Chen Tianwen, Zeng Wen, Guo Yawen, Huang T |
| Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis. Critical reviews in oncology/hematology 2016 Jan . Passiglia Francesco, Bronte Giuseppe, Bazan Viviana, Galvano Antonio, Vincenzi Bruno, Russo Anton |
| THE RELATIONSHIP OF BRAF MUTATION STATUS TO FDG PET/CT AVIDITY IN THYROID CANCER: A REVIEW AND META-ANALYSIS. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2017 11 24 (1): 21-26. Santhanam Prasanna, Khthir Rodhan, Solnes Lilja B, Ladenson Paul |
| Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China. Diagnostic pathology 2019 Jul 14 (1): 74. Huang Meiling, Yan Changjiao, Xiao Jingjing, Wang Ting, Ling R |
| The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis. Frontiers in oncology 2020 10 540238. Zhao Ling, Wang Lin, Jia Xiaomeng, Hu Xiaodong, Pang Ping, Zhao Sitong, Wang Yajing, Wang Jing, Zhang Yingshi, Lyu Zhaoh |
| Hashimoto's Thyroiditis: A "Double-Edged Sword" in Thyroid Carcinoma. Frontiers in endocrinology 2022 3 13 801925. Xu Jiangyue, Ding Ke, Mu Lan, Huang Jiangsheng, Ye Fei, Peng Yu, Guo Can, Ren Chuto |
| BRAF V600E Mutation in Ameloblastoma: A Systematic Review and Meta-Analysis. Cancers 2022 11 14 (22): . Mamat Yusof Mohd Nazzary, Ch'ng Ewe Seng, Radhiah Abdul Rahman Naw |
| Differential Profile of Primary and Recurrent Ameloblastomas Among Afro-descendants and Non-Afro-descendants-a Systematic Review. Journal of racial and ethnic health disparities 2023 1 . Patel Parth, Effiom Olajumoke A, Akinshipo Abdul-Warith O, Akintoye Sunday |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: